Definium Therapeutics (DFTX) EPS (Basic) (2021 - 2026)
Definium Therapeutics' (DFTX) quarterly EPS (Basic) came in at -$0.71 in Q1 2026, down 158.21% year-on-year from $1.22 in Q1 2025, and down 25.51% on a QoQ basis from -$0.56 in Q4 2025.
Definium Therapeutics (DFTX) EPS (Basic) (2021 - 2026) Analysis & Trends
Definium Therapeutics (DFTX) has 6 years of EPS (Basic) data on file, last reported at -$0.71 in Q1 2026.
- On a quarterly basis, EPS (Basic) fell 158.21% year-over-year to -$0.71 in Q1 2026; TTM through Mar 2026 was -$2.18, a 139.28% decrease from a year earlier, with the FY2025 full-year figure at -$2.06, down 33.4% from the prior year.
- EPS (Basic) for Q1 2026 stood at -$0.71, down from -$0.56 in the prior quarter.
- Over the last five years, EPS (Basic) for DFTX reached as high as -$0.08 in Q2 2024 and fell as low as -$1.14 in Q1 2024.
- Historically, EPS (Basic) has averaged -$0.55 across 5 years, with a median of -$0.53 in 2023.
- Across the five-year window, EPS (Basic) surged 88.73% in 2024 and slumped 515.23% in 2025, its largest moves.
- Year by year, EPS (Basic) stood at -$0.17 in 2022, then sank by 219.89% to -$0.53 in 2023, then increased by 7.23% to -$0.49 in 2024, then slipped by 14.51% to -$0.56 in 2025, then fell by 25.51% to -$0.71 in 2026.
- Per Business Quant data, the three most recent EPS (Basic) figures were -$0.71 in Q1 2026, -$0.56 in Q4 2025, and -$0.78 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 0.00 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 0.16 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 0.00 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 4.06 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 6.99 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 0.00 |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 7.59 |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -2.29 |
| 10 | Definium Therapeutics | 4.47 Bn | 4.47 Bn | - | -0.71 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.71 |
| Dec 31, 2025 | -0.56 |
| Sep 30, 2025 | -0.78 |
| Jun 30, 2025 | -0.50 |
| Mar 31, 2025 | -0.27 |
| Dec 31, 2024 | -0.49 |
| Sep 30, 2024 | -0.18 |
| Jun 30, 2024 | -0.08 |
| Mar 31, 2024 | -1.14 |
| Dec 31, 2023 | -0.53 |
| Sep 30, 2023 | -0.53 |
| Jun 30, 2023 | -0.72 |
| Mar 31, 2023 | -0.51 |
| Dec 31, 2022 | -0.17 |
| Sep 30, 2022 | -0.56 |
| Jun 30, 2022 | -0.60 |
| Mar 31, 2022 | -0.99 |
| Dec 31, 2021 | 1.69 |
| Sep 30, 2021 | -0.61 |
| Jun 30, 2021 | -1.65 |